Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis

摘要

BackgroundLate-onset Pompe disease (LOPD) is a rare, metabolic disease primarily affecting the musculoskeletal and respiratory systems. Forced vital capacity (FVC) is commonly used to measure pulmonary function; however, associations between FVC and other LOPD outcomes remain unclear.